S&P Indices Announces Changes to U.S. Index

NEW YORK, April 18, 2012 /PRNewswire/ -- S&P Indices will make the following changes to the S&P SmallCap 600 index:

• OpenTable, Inc. (NASD: OPEN) will replace ZOLL Medical Corp. (NASD: ZOLL) after the close of trading on Friday, April 20. Asahi Kasei Corp. is acquiring ZOLL in a deal expected to be completed soon, pending final conditions.
• Spectrum Pharmaceuticals, Inc. (NASD: SPPI) will replace Midas, Inc. (NYSE: MDS) after the close of trading on Tuesday, April 24.  Midas is being acquired by TBC Corp. in a deal expected to be completed soon pending final conditions.

OpenTable is a provider of real-time online restaurant reservations for diners and reservation and guest management solutions for restaurants. Headquartered in San Francisco, CA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Internet Software & Services Sub-Industry index.

Spectrum Pharmaceuticals acquires, develops, and commercializes prescription drug products. Headquartered in Henderson, NV, the company will be added to the S&P SmallCap 600 GICS Biotechnology Sub-Industry index.

Following is a summary of the changes:

About S&P Indices

S&P Indices, a leading brand of the McGraw-Hill Companies (NYSE: MHP), maintains a wide variety of investable and benchmark indices to meet an array of investor needs. Over $1.45 trillion is directly indexed to our indices, which includes the S&P 500, the world's most followed stock market index, the S&P/Case-Shiller Home Price Indices, the leading measure of U.S. home prices, the S&P Global BMI, an index with approximately 11,000 constituents, the S&P GSCI, the industry's most closely watched commodities index, and the S&P National AMT-Free Municipal Bond Index, the premier investable index for U.S. municipal bonds. For more information, please visit: www.standardandpoors.com/indices.

It is not possible to invest directly in an index. S&P Indices does not sponsor, endorse, sell, or promote any S&P index-based investment product. This document does not constitute an offer of services in jurisdictions where S&P Indices or its affiliates do not have the necessary licenses. S&P Indices receives compensation in connection with licensing its indices to third parties.

For more information:

Dave Guarino
Communications
S&P Indices
[email protected]
212-438-1471

David Blitzer
Managing Director and Chairman of the Index Committee
S&P Indices
[email protected]
212-438-3908

SOURCE S&P Indices